(INNF)
UTOMILUMAB(INNS)
UTOMILUMAB(SLE)
UTOMILUMAB(INNC)
IMMUNOGLOBULIN G2-LAMBDA, ANTI-[HOMO SAPIENS TNFRSF9 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 9, 4-1BB, T CELL ANTIGEN ILA, CD137)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN (1-442) [HOMO SAPIENS VH (IGHV5- 10-1*04 (94.90%) -(IGHD)-IGHJ4*01) [8.8.9] (1-116) - IGHG2*01, G2M.. (CH1 (117-214), HINGE (215-226), CH2 (227-335), CH3 (336-440), CHS (441-442)) (117-442)], (130-213')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-214') [HOMO SAPIENS V-LAMBDA (IGLV3-1*01 (90.00%) -IGLJ7*01) [6.3.11] (1'-108') -IGLC2*01 (109'-214')]; DIMER (218- 218'':219-219'':222-222'':225-225'')-TETRAKISDISULFIDE, RECOMMENDED INN: LIST 77(WHO)
UTOMILUMABUM(INN)